Why Earnings Season Could Be Great for Satsuma Pharmaceuticals (STSA)Zacks Investment Research • 05/10/21
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business HighlightsGlobeNewsWire • 03/25/21
Satsuma: Launch Of 2nd Pivotal Trial For Migraine Med Ought To Cheer Share PriceSeeking Alpha • 03/07/21
Satsuma Pharma Shares Rise After Raising $80M Via Private Placement, Plans New Pivotal Study For MigraineBenzinga • 03/01/21
Satsuma Pharmaceuticals to Participate in the Evercore ISI 3rd Annual HealthCONx Conference GlobeNewsWire • 11/24/20
Satsuma Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial ResultsGlobeNewsWire • 11/10/20
Satsuma Pharmaceuticals to to participate in the following November Virtual Investor ConferencesGlobeNewsWire • 11/02/20
Satsuma Pharmaceuticals to Participate in September Virtual Investor ConferencesGlobeNewsWire • 09/03/20
Satsuma Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial ResultsGlobeNewsWire • 08/12/20
Satsuma Pharmaceuticals Announces Enrollment of First Patient in the ASCEND™ Phase 3 open-label, safety trial of STS101GlobeNewsWire • 08/06/20
Satsuma Pharmaceuticals Announces the Appointment of Thomas M. Soloway to its Board of DirectorsGlobeNewsWire • 07/07/20
Satsuma Pharmaceuticals to Present Two Posters at the American Headache Society’s Annual Scientific Meeting Hosted via a Virtual Meeting PlatformGlobeNewsWire • 06/11/20
Satsuma Completes Enrollment in Pivotal Phase 3 EMERGE trial of STS101 for Acute Treatment of MigraineGlobeNewsWire • 06/01/20
Satsuma Pharmaceuticals Reports First Quarter 2020 Financial and Business ResultsGlobeNewsWire • 05/12/20
Satsuma Pharmaceuticals to Present at the 9th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/18/20
Satsuma Pharmaceuticals Announces Publication of STS101 Phase 1 Clinical Trial Results in HEADACHE: The Journal of Head and Face PainGlobeNewsWire • 01/28/20
Satsuma Pharmaceuticals to Present at the 2nd Annual Evercore ISI HealthCONx ConferenceGlobeNewsWire • 11/26/19